Business News • PR NewsWire • Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology

Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology

Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology

THOUSAND OAKS, Calif. and GAITHERSBURG, Md., Oct. 3, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and AstraZeneca (AZN), with its biologics research and development arm MedImmune, today announced the upcoming presentation of several key studies evaluating brodalumab, a human...

View More : http://www.prnewswire.com/news-releases/amgen-and-astrazeneca-highlight-data-to-be-presented-at-22nd-congress-of-the-eur...

Releted News by prnewswire

Simposio destinado a resaltar la aplicación práctica de nuevos biomarcadores para el daño renal agudo

Simposio per evidenziare l'utilizzo pratico del nuovo test dei biomarcatori per grave insufficienza renale